Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17082-09-6

Post Buying Request

17082-09-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17082-09-6 Usage

Description

Cinnamoyl Chloride, also known as 3-phenylpropenoyl chloride, is an organic compound derived from cinnamic acid. It is a colorless to pale yellow liquid with a pungent odor and is commonly used as a chemical intermediate in the synthesis of various pharmaceuticals and other organic compounds. Its reactivity and functional groups make it a versatile building block in organic chemistry.

Uses

Used in Pharmaceutical Industry:
Cinnamoyl Chloride is used as a chemical intermediate for the synthesis of aminodihydroquinoline analogs, which exhibit anticancer activity. These analogs are being investigated for their potential in treating various types of cancer by targeting specific cellular pathways and mechanisms.
Used in Antibacterial Applications:
Cinnamoyl Chloride is also used in the preparation of lysergol and related derivatives, which have demonstrated antibacterial properties. These compounds are being explored for their potential use in the development of new antibiotics to combat drug-resistant bacterial infections.

Check Digit Verification of cas no

The CAS Registry Mumber 17082-09-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,0,8 and 2 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 17082-09:
(7*1)+(6*7)+(5*0)+(4*8)+(3*2)+(2*0)+(1*9)=96
96 % 10 = 6
So 17082-09-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H9Cl/c10-8-4-7-9-5-2-1-3-6-9/h1-7H,8H2/b7-4+

17082-09-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (P0133)  Cinnamoyl Chloride  >97.0%(T)

  • 17082-09-6

  • 25g

  • 190.00CNY

  • Detail
  • TCI America

  • (P0133)  Cinnamoyl Chloride  >97.0%(T)

  • 17082-09-6

  • 500g

  • 920.00CNY

  • Detail
  • Alfa Aesar

  • (A12016)  trans-Cinnamoyl chloride, 97%   

  • 17082-09-6

  • 100g

  • 307.0CNY

  • Detail
  • Alfa Aesar

  • (A12016)  trans-Cinnamoyl chloride, 97%   

  • 17082-09-6

  • 500g

  • 881.0CNY

  • Detail
  • Alfa Aesar

  • (A12016)  trans-Cinnamoyl chloride, 97%   

  • 17082-09-6

  • 2500g

  • 3900.0CNY

  • Detail

17082-09-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name Trans-3-Phenylacryloyl Chloride

1.2 Other means of identification

Product number -
Other names CINNAMOYL CHLORIDE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17082-09-6 SDS

17082-09-6Relevant articles and documents

Design, Synthesis, and Anticancer Activity of Cinnamoylated Barbituric Acid Derivatives

Li, Peng-Xiao,Liu, Guo-Yun,Liu, Ren-Min,Liu, Yue,Mu, Wen-Wen,Sun, Ya-Lei,Yang, Jie

, (2022/01/13)

This work deals with the design and synthesis of 18 barbituric acid derivatives bearing 1,3-dimethylbarbituric acid and cinnamic acid scaffolds to find potent anticancer agents. The target molecules were obtained through Knoevenagel condensation and acylation reaction. The cytotoxicity was assessed by the MTT assay. Flowcytometry was performed to determine the cell cycle arrest, apoptosis, ROS levels and the loss of MMP. The ratios of GSH/GSSG and the MDA levels were determined by using UV spectrophotometry. The results revealed that introducing substitutions (CF3, OCF3, F) on the meta- of the benzyl ring of barbituric acid derivatives led to a considerable increase in the antiproliferative activities compared with that of corresponding ortho- and para-substituted barbituric acid derivatives. Mechanism investigation implied that the 1c could increase the ROS and MDA level, decrease the ratio of GSH/GSSG and MMP, and lead to cell cycle arrest. Further research is needed for structural optimization to enhance hydrophilicity, thereby improve the biological activity of these compounds.

PCl3-mediated transesterification and aminolysis of tert-butyl esters via acid chloride formation

Wu, Xiaofang,Zhou, Lei,Li, Fangshao,Xiao, Jing

, p. 491 - 497 (2021/01/20)

A PCl3-mediated conversion of tert-butyl esters into esters and amides in one-pot under air is developed. This novel protocol is highlighted by the synthesis of skeletons of bioactive molecules and gram-scale reactions. Mechanistic studies revealed that this transformation involves the formation of an acid chloride in situ, which is followed by reactions with alcohols or amines to afford the desired products.

Meta-substituted piperlongumine derivatives attenuate inflammation in both RAW264.7 macrophages and a mouse model of colitis

Gong, Zhaotang,Liu, Guoyun,Mu, Wenwen,Wang, Ziqing,Yang, Jie

, (2021/11/16)

Piperlongumine (PL) has been showed to have multiple pharmacological activities. In this study, we reported the synthesis of three series of PL derivatives, and evaluation of their anti-inflammatory effects in both lipopolysaccharide (LPS)-induced Raw264.7 macrophages and a dextran sulfate sodium (DSS)-induced mouse model of colitis. Our results presented that two meta-substituent containing derivatives 1–3 and 1–6, in which γ-butyrolactam replaced α,β-unsaturated δ-valerolactam ring of PL, displayed low cytotoxicity and effective anti-inflammatory activity. Molecular docking also showed that the meta-substituted derivative, compared with the corresponding ortho- or para-substituted derivative, had significant interactions with the amino acid residues of CD14, which was the core receptors recognizing LPS. In vitro and in vivo studies, 1–3 and 1–6 could inhibit the expression of pro-inflammatory cytokines, and the excessive production of reactive nitrogen species and reactive oxygen species. Oral administration of 100 mg/kg/day of 1–3 or 1–6 alleviated the severity of clinical symptoms of colitis in mice, and significantly reduced the colonic tissue damage to protect the colonic tissue from the DSS-induced colitis. These results suggested that meta-substituted derivatives 1–3 and 1–6 were potential anti-inflammatory agents, which may lead to future pharmaceutical development.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17082-09-6